Innovative pharma companies are adopting increasingly aggressive strategies to prolong the life of their product patents and keep generic p...

Sun Pharmaceuticals has prepared a war chest of $500 million for acquisitions in the US, as it bets big on the world's largest drugs market.

If Sun Pharmaceutical succeeds in its challenge against Eli Lilly’s patent on cancer drug, it could reap a windfall.

Domestic pharma majors are witnessing sharp recovery in their US business.

In spite of steep pricing pressure and increasing competition, domestic pharma majors, including Ranbaxy Labs, Dr Reddy’s Labs, Cipla and S...